Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
HA14-1 suppressed NF-kappaB activation through inhibition of phosphorylation and degradation of IkappaBalpha
AZD2906 shows IC50s of 2
Fecal concentrations of lactic acid are not significantly affected by the experimental diets (4
but not ER-negative (MDA-MB-231) breast cancer cells
indicating that CGP 25454A is able to enhance the release of both dopamine (DA) and acetylcholine (ACh)
L-R4W2 Catalog No.:M21426-C HA14-1 suppressed NF-kappaB activation throughL R4W2 is a potent antagonist of vanilloid receptor 1 (VR1, TRPV1), with an IC50 of 0. 1 M. L R4W2 may act as a potent analgesic. Product information CAS Number: 206350 79 0 Molecular Weight: 1014. 19 Formula: C46H71N21O6 Chemical Name: (Z,2S) 2 [(Z) [(2S) 2 [(Z) [(2S) 2 [(Z) [(2S) 2 amino 5 carbamimidamido 1 hydroxypentylidene]amino] 5 carbamimidamido 1 hydroxypentylidene]amino] 5 carbamimidamido 1 hydroxypentylidene]amino] 5 carbamimidamido N [(1S)
US$ 345.00
US$ 150.00
US$ 140.00
US$ 940.00
US$ 380.00
US$ 1650.00
US$ 360.00
US$ 375.00
US$ 29.95